ID: ALA2420545

Max Phase: Preclinical

Molecular Formula: C16H18FN3O3S

Molecular Weight: 351.40

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1ccc(NC(=O)Nc2cccc(F)c2)cc1S(=O)(=O)N(C)C

Standard InChI:  InChI=1S/C16H18FN3O3S/c1-11-7-8-14(10-15(11)24(22,23)20(2)3)19-16(21)18-13-6-4-5-12(17)9-13/h4-10H,1-3H3,(H2,18,19,21)

Standard InChI Key:  QOJFAVDUJMWKRH-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 351.40

Molecular Weight (Monoisotopic): 351.1053

AlogP: 3.03

#Rotatable Bonds: 4

Polar Surface Area: 78.51

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.27

CX Basic pKa:

CX LogP: 2.83

CX LogD: 2.83

Aromatic Rings: 2

Heavy Atoms: 24

QED Weighted: 0.89

Np Likeness Score: -2.29

References

1. Ramos-Hunter SJ, Engers DW, Kaufmann K, Du Y, Lindsley CW, Weaver CD, Sulikowski GA..  (2013)  Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.,  23  (18): [PMID:23916258] [10.1016/j.bmcl.2013.07.002]

Source

Source(1):

• Scientific Literature